Shots:
- Kaia Health signs an exclusive agreement with Chiesi Group to commercialize the Kaia Health COPD Pulmonary Rehabilitation app in the EU
- The app is CE marked in EU as a Class 1 medical device and has been investigated in one pilot trial and is the subject of an ongoing randomized control trial in the EU
- The Kaia COPD solution consists of a mobile app and an interface for motivational support that aims to deliver a personalized pulmonary rehabilitation experience through education, daily training sessions, and stress relief exercises, boosted with human coaching support and individualized therapy
Click here to read full press release/ article | Ref: Kaia Health | Image: Venture Beat
The post Kaia Health Allied with Chiesi Group to Commercialize COPD App in Europe first appeared on PharmaShots.
